DAIC

APRIL 6, 2024

The Minneapolis Heart Institute Foundation (MHIF) is presenting leading research focused on trends in ST-elevation myocardial infarction (STEMI), the most severe form of a heart attack, at the American College of Cardiology’s Annual Scientific Session (ACC.24), 24), being held April 6-8 in Atltanta, GA.

Heart Attack 52

Heart Attack Heart attacks Risk Factors Research 52

DAIC

FEBRUARY 29, 2024

Five highly-anticipated late-breaking clinical trial sessions, an ACC/AHA guidelines update session and a host of featured clinical research sessions have been announced by program planners for the American College of Cardiology’s 73 rd Annual Scientific Session & Expo to be held April 6-8 in Atlanta, GA.

Aortic valve 103

Aortic valve Myocardial Infarction Aortic Blood Pressure 103

Circulation

NOVEMBER 11, 2024

Owing to improved management, the life expectancy of patients with hemophilia has increased significantly and predisposes them to risk of cardiovascular diseases and thrombotic events. The primary outcome was to estimate the prevalence of cardiovascular risk factors in patients with hemophilia compared to the general population.

Risk Factors 40

Risk Factors Cardiovascular Disease Coronary Artery Bypass Graft Outcomes 40

Frontiers in Cardiovascular Medicine

JANUARY 9, 2024

Background and aims It is uncertain if there is a link between non-alcoholic fatty liver disease (NAFLD) and cardiovascular diseases (CVD) in young adults and children. Further subgroup analyses showed that individuals with NAFLD were at a heightened risk of coronary heart disease (CHD) (HR = 3.10, 95% CI: 2.01–4.77,

Cardiovascular Disease 59

Cardiovascular Disease Myocardial Infarction Atrial Fibrillation Heart Failure 59

Circulation: Genomic and Precision Medicine

NOVEMBER 28, 2023

Background:Proteomic profiling could potentially disclose new pathophysiological pathways for cardiovascular diseases (CVD) and improve prediction at the individual level. In separate meta-analyses for each of the 3 CVD outcomes, 49 proteins were related to myocardial infarction, 34 to ischemic stroke, and 109 to heart failure.

Cardiovascular Disease 40

Cardiovascular Disease Myocardial Infarction Obesity Heart Failure 40

Frontiers in Cardiovascular Medicine

JANUARY 23, 2024

Introduction Cardiovascular disease (CVD) is the leading cause of morbidity and mortality in kidney transplant recipient (KTR). There is a dearth of standardized guidelines on optimal cardiovascular evaluation of transplant candidates. Conclusion Asymptomatic CVD is largely prevalent in KTR.

Transplant 64

Transplant Coronary Artery Disease Myocardial Infarction Cardiovascular Disease 64

Dr. Smith's ECG Blog

NOVEMBER 15, 2023

Contemporary research studies of MINOCA have evaluated the prognosis of these patients, reporting a 12-month all-cause mortality of 4.7% (95% confidence interval, 2.6–6.9), 6.9), 3 with comparative studies consistently demonstrating a better prognosis than for those who experience AMI associated with obstructive coronary artery disease.

Coronary Angiogram 109

Coronary Angiogram Plaque Thrombosis STEMI 109

Coronary Artery Disease Journal

DECEMBER 1, 2024

Background Lipoprotein(a) [Lp(a)] is an independent risk factor for cardiovascular disease due to its unique apo(a) component and its association with atherosclerosis and thrombogenesis. In terms of safety, there was no increased risk of adverse reactions other than injection site reactions.

Heart Disease 40

Heart Disease Cholesterol Myocardial Infarction Atherosclerosis 40

Cardiometabolic Health Congress

APRIL 19, 2024

Prior Indications in the U.S.: To reduce the risk of myocardial infarction, stroke, and unstable angina requiring hospitalization in adults with established cardiovascular disease.

Pediatrics 52

Pediatrics Diet Cholesterol Cardiovascular Disease 52

Dr. Malcolm Kendrick

AUGUST 26, 2022

26th August 2022 And so, after a great deal of faffing about, my article on cardiovascular disease ‘Assessing cardiovascular disease: looking beyond cholesterol’ has been made free to view. Eric Westman is a staunch ally in the crusade to look at different causal models of cardiovascular disease.

Cardiovascular Disease 40

Cardiovascular Disease Cholesterol Article Plaque 40

Open Heart

MARCH 1, 2024

Introduction Hypertension is the leading modifiable risk factor for cardiovascular disease and is implicated in half of all strokes and myocardial infarctions. One-third of the adults in Scotland have hypertension yet only a quarter of them have their blood pressure (BP) controlled to target (<140/90 mm Hg).

Blood Pressure 40

Blood Pressure Education Hypertension Quality of Life 40

Dr. Smith's ECG Blog

FEBRUARY 8, 2015

We believe more research is needed in this area, as amphetamine derivatives are one of the most widely abused drugs worldwide, and we expect this problem to worsen in the future." de Lemos, J. Gibler, W. Philippides, G. Henry Ford Hospital. de Lemos, J. Gibler, W. Philippides, G. Henry Ford Hospital.

Tachycardia 52

Tachycardia Chest Pain Pharmacology Myocardial Infarction 52

DAIC

MARCH 31, 2025

mg reduces the risk of major adverse cardiovascular events (MACE) and supports its use in the treatment of cardiovascular disease. mg)has potential to directly reduce inflammation, which plays a substantial role in the formation and progression of atherosclerotic plaque leading to heart disease, said Matthew J.

Cardiovascular Disease 52

Cardiovascular Disease Plaque Coronary Artery Disease Heart Attack 52

Dr. Smith's ECG Blog

NOVEMBER 30, 2022

Such cases are classified as MINOCA (Myocardial Infarction with Non-Obstructed Coronary Arteries). Contemporary research studies of MINOCA have evaluated the prognosis of these patients, reporting a 12-month all-cause mortality of 4.7% (95% confidence interval, 2.6–6.9), It can only be seen by IVUS. MINOCA has many etiologies.

Plaque 52

Plaque Chest Pain Thrombosis Stenosis 52

Frontiers in Cardiovascular Medicine

FEBRUARY 6, 2025

Cardiovascular diseases are the most lethal diseases worldwide, of which myocardial infarction is the leading cause of death. A growing body of research suggests that the loss of cardiac regenerative capacity is closely related to metabolic shifts in energy sources.

Myocardial Infarction 52

Myocardial Infarction Cardiovascular Disease Research 52

Cardiometabolic Health Congress

FEBRUARY 1, 2024

The profound link between the heart and mind has been the subject of much research for some time, with newer studies reinforcing the existing evidence as well as offering deeper insights. As we step into American Heart Month, it becomes imperative to delve into the intricacies of this relationship and dissect the latest research findings.

Cardiovascular Disease 105

Cardiovascular Disease Coronary Artery Bypass Graft Heart Disease Risk Factors 105

Cardiometabolic Health Congress

JANUARY 15, 2025

Atherosclerosisa key driver of cardiovascular disease (CVD)continues to be a significant global health issue. For example, the global spread of obesity, particularly among youth, has set the stage for a future pandemic of non-communicable diseases. Improving Access: Advocate for equitable healthcare resources worldwide.

Atherosclerosis 59

Atherosclerosis Plaque Myocardial Infarction Risk Factors 59

DAIC

JANUARY 23, 2024

Atherosclerotic cardiovascular disease (ASCVD), caused by plaque buildup in arterial walls, is one of the leading causes of disability and death worldwide.1,2 1,2 ASCVD causes or contributes to conditions that include coronary artery disease (CAD), cerebrovascular disease, and peripheral vascular disease (inclusive of aortic aneurysm).3

Cardiovascular Disease 111

Cardiovascular Disease Heart Attack Heart attacks Coronary Artery Disease 111

Medical Xpress - Cardiology

APRIL 3, 2024

Cardiovascular diseases, including myocardial infarction and stroke, are the world's leading cause of death, claiming around 18 million lives a year.

Research 84

Research Myocardial Infarction Cardiovascular Disease Stroke 84

DAIC

MARCH 31, 2025

mg reduces the risk of major adverse cardiovascular events (MACE) and supports its use in the treatment of cardiovascular disease. mg)has potential to directly reduce inflammation, which plays a substantial role in the formation and progression of atherosclerotic plaque leading to heart disease, said Matthew J.

Cardiovascular Disease 52

Cardiovascular Disease Plaque Coronary Artery Disease Heart Attack 52

Frontiers in Cardiovascular Medicine

AUGUST 6, 2024

Myocardial infarction (MI) stands at top global causes of death in developed countries, owing mostly to atherosclerotic plaque growth and endothelial injury-induced reduction in coronary blood flow. While early reperfusion techniques have improved outcomes, long-term treatment continues to be difficult.

Myocardial Infarction 52

Myocardial Infarction Plaque Physiology Cardiovascular Disease 52

Cardiovascular Diabetology

JULY 10, 2024

Background The effect of empagliflozin, a sodium-glucose-co-transporter-2 inhibitor, on risk for myocardial infarction has not been fully characterized.

Myocardial Infarction 52

Myocardial Infarction Coronary Artery Bypass Graft Outcomes Plaque 52

DAIC

DECEMBER 27, 2023

The Schottenstein Prize is among the largest monetary prizes in the United States dedicated to cardiovascular research. Gerald and Myra Dorros Chair in Cardiovascular Disease at Albert Einstein and serves as director of the Einstein Wilf Family Cardiovascular Research Institute.“Dr.

Heart Attack 111

Heart Attack Heart attacks Research Myocardial Infarction 111

DAIC

JUNE 19, 2024

While the spotlight in 2023 shone on developments around Generative Artificial Intelligence (AI), away from the limelight a quiet revolution in AI was taking place, which promises to transform the way we diagnose, manage, and treat cardiovascular diseases, the world’s leading cause of death.

AFIB 105

AFIB Reimbursement Research Atrial Fibrillation 105

DAIC

MAY 14, 2024

Within the complex umbrella of cardiovascular disease, CAD is a type of heart disease that develops when the coronary arteries narrow and the heart cannot deliver enough oxygen-rich blood to the heart.

Coronary Artery Disease 111

Coronary Artery Disease Interventional Cardiology Innovation Physiology 111

DAIC

APRIL 30, 2024

In a recent study, researchers from Japan tested a novel approach that involves injecting ‘cardiac spheroids,’ cultured from human stem cells, directly into damaged ventricles. Cardiovascular diseases are still among the top causes of death worldwide, and especially prevalent in developed countries.

Transplant 105

Transplant Heart Transplant Myocardial Infarction Heart Attack 105

Frontiers in Cardiovascular Medicine

DECEMBER 9, 2024

BackgroundThe peak incidence of cardiovascular diseases (CVD) usually occurs in the morning.

Myocardial Infarction 52

Myocardial Infarction STEMI Risk Factors Cardiovascular Disease 52

DAIC

JANUARY 25, 2024

The companies will jointly support a series of educational forums among clinicians beginning later this year highlighting the significant new scientific breakthroughs that are radically transforming the traditional approach to heart disease prevention and prediction. mg tablets for therapeutic intervention.

Heart Attack 110

Heart Attack Heart attacks Technology Cardiovascular Disease 110

Frontiers in Cardiovascular Medicine

FEBRUARY 11, 2025

BackgroundThe acute myocardial infarction (AMI) is a prevalent and severe cardiovascular disease, characterized by its sudden onset, high mortality rate, and unfavorable prognosis.

Myocardial Infarction 52

Myocardial Infarction Diabetes Heart Failure Laboratory 52

European Journal of Heart Failure

DECEMBER 18, 2024

Abstract Aims The relationship between body mass index (BMI) and clinical outcomes in patients with cardiovascular disease, including acute heart failure (AHF) and acute myocardial infarction (AMI), remains debated.

Myocardial Infarction 40

Myocardial Infarction BMI Outcomes Heart Failure 40

Journal of the American Heart Association

NOVEMBER 28, 2023

BackgroundCarotid intima‐media thickness (cIMT) has been widely used as a predictor of future cardiovascular disease (CVD); however, various definitions of cIMT exist. Further research is warranted to validate our findings and to standardize the cIMT measurement protocol, as well as to explore underlying mechanisms.

Cardiovascular Disease 40

Cardiovascular Disease Article Myocardial Infarction Stroke 40

Open Heart

DECEMBER 7, 2023

However, it is not clear to what extent chronic cardiovascular dysfunction might mediate these functional impairments, or how we might screen and manage these patients at risk of chronic cardiovascular disease. Conclusion There are significant gaps in our understanding of cardiac dysfunction following sepsis.

Article 52

Article Myocardial Infarction Cardiovascular Imaging Biomarkers 52

Cardiometabolic Health Congress

JULY 25, 2023

There are significant data that show that if you have obesity, you have a high risk of developing coronary heart disease, heart failure, type 2 diabetes (T2D) or risk factors such as hypertension and dyslipidemia. [1] 5, 6] So, it seems that once cardiovascular disease is present, then obesity may offer some degree of protection.

Obesity 52

Obesity BMI Heart Failure Cardiovascular Disease 52

European Journal of Heart Failure

FEBRUARY 12, 2024

Left ventricular (LV) global longitudinal strain (GLS) assessed via feature tracking cardiac magnetic resonance imaging is associated with increased risk of major adverse cardiovascular events (MACE). LV GLS is associated with MACE in adults without prevalent cardiovascular disease (CVD). 2.38, p  = 0.04).

Cardiovascular Disease 40

Cardiovascular Disease Biomarkers Myocardial Infarction Heart Failure 40

Cardiovascular Diabetology

NOVEMBER 20, 2024

Methods A nationwide cohort study was conducted with 896,585 young adults under 40 years old without diabetes or previous history of cardiovascular disease. The outcomes of this study were incident diabetes (DM) and composite major adverse cardiovascular events (MACE), including myocardial infarction, stroke, or cardiovascular death.

Outcomes 52

Outcomes Myocardial Infarction Diabetes Cardiovascular Disease 52

Frontiers in Cardiovascular Medicine

JANUARY 9, 2025

BackgroundThe prognostic value of triglyceride-glucose (TyG) has been well described in patients with coronary artery disease (CAD). Hyperhomocysteinemia (HHcy) promotes insulin resistance and has also been regarded as a potential risk factor for cardiovascular disease.

Coronary Artery Disease 40

Coronary Artery Disease Myocardial Infarction Risk Factors Cardiovascular Disease 40

Cardiometabolic Health Congress

MAY 10, 2024

The American Heart Association’s scientific statement, “Psychological Health, Well-Being, and the Mind-Heart-Body Connection,” emphasizes the need to evaluate and address psychological health in patients with or at risk for cardiovascular disease (CVD).

Coronary Artery Disease 59

Coronary Artery Disease Obesity Chest Pain Ischemia 59